Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Detailed Certificates of Analysis (CoA) are available to support experimental reproducibility and confirm molecular weight and purity
A Differentiated Next-Generation GLP Candidate SureNano Science is advancing GEP-44 as a patented, next-generation metabolic therapy intended to improve upon limitations associated with first-generation GLP-1 drugs, positioning this emerging microcap as a minnow among giants quickly transitioning through the FDA pathway
The mechanism of action of GHK-Cu is based on several interconnected signaling pathways
Food and Drug Administration (FDA) for the treatment of type 2 diabetes and obesity
Chang W, Zhang M, Li J, Meng Z, Wei S, Du H, Chen L, Hatch GM (2013) Berberine improves insulin resistance in cardiomyocytes via activation of 5-adenosine monophosphate-activated protein kinase
Check current fulfillment details at LifeMD's official website
